Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
1500 participants
INTERVENTIONAL
2023-10-01
2031-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Myopia Acquisition and Prevention
NCT00477620
Early Intervention for Premyopic Children
NCT06200194
Light Diffraction Glasses in Preventing and Controlling Myopia in Adolescents
NCT06927414
Association of Genetic Variants With Myopia
NCT07030153
Safety and Effectiveness of CARE1.02 Spectacle Lens in Myopia Control
NCT05818033
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The axial length of an adult eye is on average around 23 millimeters. Every millimeter of additional length must be corrected with a -2.75 diopter lens.
In newborns, the eyeball is about 18 millimeters long. It is believed that there are feedback loops during childhood and adolescence to control the growth of the eye.
Epidemiological studies show that myopia is an increasing health problem. There is a growing body of epidemiological evidence that environmental factors can influence the development of myopia.
The link between the environment and myopia lies in the quality of the retinal image. Experimental studies in various species have shown that if the retinal image is missing, eye growth is disturbed. Of even greater importance for the development of myopia is the knowledge that the primate eye can change its growth, depending on the strength and type of blurring of the retinal image: if lenses are placed in front of the eye during development, the eye growth changes in such a way that a sharp retinal image is achieved through these lenses. If divergent lenses are placed in front of the eye, the eye becomes longer, and if convergent lenses are placed in front of it, it becomes correspondingly shorter.
So myopia is the result of a failure in these emmetropization mechanisms. The positive correlation of myopia with a higher level of education suggests that increased close work interferes with emmetropization. The growth in length of the eye changes in such a way that it adapts to this requirement: the eye adjusts itself to the close work: it becomes myopic.
Myopia is thus possibly a physiological adaptation to increased near work with the aim of improving the quality of the retinal image during close work. However, this can only be achieved at the expense of the image quality when looking into the distance.
The investigators submitted a study on this subject to the Cantonal Ethics Committee of the Canton of Zurich in 2003:
"An open, prospective, randomized study on the use of reading glasses in children with normal vision to prevent myopia" Unique Protocol ID: FR-2005-01-01 Approval Status: Approved Approval Number: KEK-StV-Nr. 19/03
This was and is so far the only clinical study that examined the effect of reading glasses on the development of myopia in emmetropic (normally sighted) children and has led to Patent No: US 8,511,819 B2, Aug. 20, 2013 "Prevention of myopia acquisition in children and young adults using reading glasses"
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Glasses
The participants are asked to wear reading glasses during near-work. The reading glasses have a lenspower of +2.0 diopters.
Reading glasses, +2.0 diopters
The participants in the glasses-group are asked to wear the reading glasses during near-work.
Control
Age matched children and adolescents, no intervention.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reading glasses, +2.0 diopters
The participants in the glasses-group are asked to wear the reading glasses during near-work.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Children whose parents have read and signed the declaration of consent
3. Spherical equivalent of refraction \<-0.5 dpt.
4. Distant vision in both eyes without correction 1.0
5. Willingness to wear reading glasses
6. Possibility of a five-year follow-up
Exclusion Criteria
2. Astigmatism over 1.5 diopters
3. Anisometropy greater than 1.5 diopters
4. Eye diseases that affect refraction development
6 Years
25 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Reis Augenklinik AG
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexander Reis, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Reis Augenklinik AG
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Reis Augenklinik AG
Bendern, , Liechtenstein
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SMART2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.